Fortrea
Cassandra Kennedy currently serves as the Chief Quality, Regulatory Affairs, & Sustainability Officer at Fortrea since May 2023. Prior to this role, Cassandra held various leadership positions at Labcorp Drug Development from March 2018 to May 2023, including SVP and Global Head of Regulatory Compliance & Quality Assurance. Other professional experiences include serving as Principal at Compliance Insights, LLC, and holding significant roles at Quintiles Transnational, Parexel, and Solvay Pharmaceuticals, where responsibilities encompassed quality assurance and regulatory compliance. Cassandra earned a Bachelor of Science degree in Clinical Psychology, Biology, and Chemistry from Lipscomb University and a Healthcare Compliance Certification from Seton Hall University.
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.